Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Scientific Reports|July 10, 2012
The pathophysiology of inhalational brucellosis in BALB/c miceLisa N Henning, Karen T Gillum, David A Fisher, et al.
Infection and Immunity|November 9, 2011
Pathophysiology of the rhesus macaque model for inhalational brucellosisLisa N Henning, Stephen M Miller, Dennis H Pak, et al.
Antibiotics (Basel, Switzerland)|August 26, 2023
Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic TularemiaMark M Hahn, Cheryl A Triplett, Michael S Anderson, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2025
Pharmacokinetic modeling and efficacy of ceftobiprole medocaril against pneumonic tularemia in cynomolgus macaquesMark M Hahn, Michael S Anderson, Matthew Snyder, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2017
The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus MacaquesTrudy H Grossman, Michael S Anderson, Lindsay Drabek, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus MacaquesTrudy H Grossman, Michael S Anderson, David Christ, et al.
Infection and Immunity|January 30, 2013
Pathology and pathophysiology of inhalational anthrax in a guinea pig modelVladimir Savransky, Daniel C Sanford, Emily Syar, et al.
Antimicrobial Agents and Chemotherapy|February 17, 2021
<i>In Vitro</i> and <i>In Vivo</i> Characterization of Tebipenem (TBP), an Orally Active Carbapenem, against Biothreat PathogensNicholas P Clayton, Akash Jain, Stephanie A Halasohoris, et al.
Plos One|June 3, 2022
Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeuticsRobert V House, Thomas A Broge, Todd J Suscovich, et al.
Pageof 2